NCT03133650View on ClinicalTrials.gov

A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 26, 2017

Primary Completion Date

February 23, 2026

Study Completion Date

February 23, 2026

Conditions
Esophagogastric CancerModerate to Severe Dysphagia
Interventions
DRUG

WST 11-mediated VTP therapy

Administration of WST11 in conjunction with endoscopic illumination at 753 nm emitted by a diode laser and administered to the participant by optical fibre catheters (cylindrical light diffusers) and a standard upper GI endoscope.

Trial Locations (3)

10021

Memorial Sloan - Kettering Cancer Center, New York

Weill Cornell Medical Center (Data Analysis Only), New York

Unknown

Weizmann Institute of Science, Rehovot

All Listed Sponsors
collaborator

Weizmann Institute of Science

OTHER

collaborator

Steba Biotech S.A.

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER